Zusammenfassung
Bei der Chorea handelt es sich um unwillkürliche, abrupt einschießende, nichtrepetitive, distal betont am ganzen Körper auftretende Hyperkinesen, die auf eine Läsion des Striatums zurückzuführen sind. Man kann genetische Formen, deren wichtigster Vertreter die Huntington-Erkrankung (HD) ist, von symptomatischen Formen, wie z. B. der Sydenham-Chorea, unterscheiden.
This is a preview of subscription content, log in via an institution to check access.
Literatur
Zitierte Literatur
Albin RL, Young AB, Penney JB (1989) The functional anatomy of disorders of the basal ganglia disorders. Trends Neurosci 12:366–375
Burgunder J-M (2013) Recent advances in the management of choreas. Ther Adv Neurol Disord 6:117–127
Chang R, Liu X, Li S, Li XJ (2015) Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy. Drug Des Devel Ther 9:2179–2188
Deutsche Gesellschaft für Neurologie (DGN) Leitlinie Chorea. AWMF-Leitlinie Nr. 030/028 2011. http://www.awmf.org
Galvan L, Andre VM, Wang EA, Cepeda C, Levine MS (2012) Functional differences between direct and indirect striatal output pathways in Huntington’s disease. J Huntingtons Dis 1:17–25
Gras D, Jonard L, Roze E, Chantout-Bastaraud S, Koht J et al (2012) Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene. J Neurol Neurosurg Psychiatry 83:956–962
Huntington Study Group (2006) Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 66:366–372
Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983
Labbadia J, Morimoto RI (2013) Huntington’s disease: underlying molecular mechanisms and emerging concepts. Trends Biochem Sci 38:378–385
Martino D, Stamelou M, Bhatia KP (2013) The differential diagnosis of Huntington’s disease-like syndromes: ‚red flags‘ for the clinician. J Neurol Neurosurg Psychiatry 84:650–656
Mencacci NE, Carecchio M (2016) Recent advances in genetics of chorea. Curr Opin Neurol 29:486–495
Myers RH, MacDonald ME, Koroshetz WJ et al (1993) De novo expansion of a (CAG)n repeat in sporadic Huntington’s disease. Nat Gen 5:168–173
Padberg G, Bruyn GW (1986) Chorea: differential diagnosis. In: Vinken PJ, Bruyn GW, Klawans HL (Hrsg) Handbook of clinical neurology, Bd 49. Elsevier, Amsterdam, S 549–564
Peall KJ, Kurian MA (2015) Benign hereditary chorea: an update. Tremor Other Hyperkinet Mov (NY) 5:314. https://doi.org/10.7916/D8RJ4HM5
Ravina B, Romer M, Constantinescu R et al (2008) The relationship between CAG repeat length and clinical progression in Hunrington’s disease. Mov Disord 23:1223–1227
Rollnik JD (2015) Morbus Huntington. Nervenarzt 86:725–735
Shimohata T, Hara K, Sanpei K et al (2007) Novel locus for benign hereditary chorea with adult onset maps to chromosome 8q21.3–q23.3. Brain 130:2302–2309
Töpper R, Schwarz M, Noth J (1999) Klinik, Pathophysiologie und klinische Neurophysiologie der Chorea. Klin Neurophysiol 30:81–89
Ueno S, Maruki Y, Nakamura M et al (2001) The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis. Nat Gen 2:121–122
Weindl A, Conrad B (2005) Chorea. In: Ceballos-Baumann AO, Conrad B (Hrsg) Bewegungsstörungen. Thieme, Stuttgart, S 195–221
Zomorrodi A, Wald ER (2006) Sydenham’s chorea in western Pennsylvania. Pediatrics 117:e675–e679
Weiterführende Literatur
Breedveld GJ, Percy AK, MacDonald ME et al (2002) Clinical and genetic heterogeneity in benign hereditary chorea. Neurology 59:579–584
Brewer GJ, Yuzbasian-Gurkan V (1992) Wilson’s disease. Medicine 71:139–164
Brewer GJ, Johnson V, Dick RD (1996) Treatment of Wilson disease with ammonium tetrathiomolyb–date. Arch Neurol 53:1017–1025
Brewer GJ, Hedera P, Kluin KJ et al (2003) Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 60:379–385
Bruyn GW, Went LN (1986) Huntington’s chorea. In: Vinken PJ, Bruyn GW, Klawans HL (Hrsg) Handbook of clinical neurology, Bd 49. Elsevier, Amsterdam/New York, S 267–314
Danek A (2002) Fortschritte in der molekularen Choreadiagnostik: McLeod-Syndrom und Chorea-Akanthozytose. Nervenarzt 73:564–569
Kleiner-Fisman G, Lang AE (2007) Benign hereditary chorea revisited: a journey to understanding. Mov Disord 22:2297–2305
Moumne L, Betuing S, Caboche J (2013) Multiple aspects of gene dysregulation in Huntington’s disease. Front Neurol 4:127. https://doi.org/10.3389/fneur.2013.00127
Reilmann R, Leavitt BR, Ross CA (2014) Diagnostic criteria for Huntington’s disease based on natural history. Mov Disord 29:1335–1341
Walker RH, Jung HH, Dobson-Stone C et al (2007) Neurologic phenotypes associated with acanthocytosis. Neurology 68:92–98
Zhao T, Hong Y, Li X-J, Li S-H (2016) Subcellular clearance and accumulation of Huntington Disease protein: a mini-review. Front Mol Neurosci 9:27. https://doi.org/10.3389/fnmol.2016.00027. eCollection 2016
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this entry
Cite this entry
Schwarz, M. (2018). Chorea. In: Berlit, P. (eds) Klinische Neurologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44768-0_135-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-44768-0_135-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44768-0
Online ISBN: 978-3-662-44768-0
eBook Packages: Springer Referenz Medizin